This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds aren’t enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
This study looked at the outcomes of surgeries for vagus nerve stimulation (VNS) in children with drug-resistant epilepsy.
Researchers studied the long-term effects of vagus nerve stimulation (VNS) on people with Dravet syndrome, a severe form of epilepsy.
This study looked at epilepsy in patients with 8p-related disorders, which are genetic conditions linked to changes on the short arm of chromosome 8.
This study looked at how well a wrist-worn device called Embrace2 can detect seizures in patients at an epilepsy monitoring unit (EMU).
This study looked at a new medication called ES-481, which is being developed to help people with drug-resistant epilepsy.
Researchers studied how the timing of biological rhythms affects seizures in people with epilepsy.
A study was conducted on a 16-year-old patient with drug-resistant epilepsy (DRE), which means their seizures did not respond to standard treatments.
Researchers studied a group of 32 individuals with a specific brain condition called bilateral frontal periventricular nodular heterotopia (PVNH).
Researchers studied sleep patterns in people with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that affects development and causes multiple types of seizures.